Chemesis International Inc. & Rapid Dose Therapeutics Sign Agreement to Bring QuickStrip™ Oral Thin Strips to Michigan
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
Chemesis International Inc. & Rapid Dose Therapeutics Sign Agreement to Bring QuickStrip™
Oral Thin Strips to Michigan
Rapid Dose Therapeutics grants Chemesis with Gold Vendor Status to license, manufacture, distribute and
sell RDT’s QuickStrip™
June 27, 2019
Vancouver, BC – Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or
“Chemesis”), and Rapid Dose Therapeutics Inc. (“RDT”), are proud to announce they have signed an
additional definitive agreement to bring QuickStrip™ Oral Thin Strips to the state of Michigan. The
Company previously announced a definitive agreement to produce QuickStrips™ for the state of California
and subsequently to bring QuickStrips™ to Puerto Rico.
“We are focused and committed to providing consumers in the US medical and recreational cannabis
markets a Smoke -Free Choice™.” said Mark Upsdell, CEO of RDT. “RDT will continue to expand our
strategic global partnerships and further strengthen our marke t share in the cannabis sector. This
agreement with Chemesis improves the QuickStrip™ position as a growing international brand and
delivery device to Michigan consumers, while simultaneously offering health benefits and improving
patient outcomes.”
RDT’s proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral fast -dissolving
drug delivery system that offers a No Smoke, No Smell, No Stigma™ product to consumers. Chemesis
expects to produce and distribute QuickStrip™ in Michigan by the end of 2019.
“Chemesis continues to have an incredible partnership with RDT, we are extremely excited to bring
QuickStrip™ Oral Thin Strips to another state,” said CEO of Chemesis, Edgar Montero. “Chemesis has
recently announced the commercialization of QuickStrip™ Oral Thin Strips in Puerto Rico, a significant step
forward to bringing large scale distribution across the United States and other markets. Chemesis believes
its partnership with RDT will continue to bring value to its shareholders.”
As part of the Agreement, Chemesis maintains the option to add future markets as the opportunity in
those regions evolve.
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated U.S. Multi -State operator with International
operations in Puerto Rico, and Colombia.
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
The Company focuses on prudent ca pital allocation to ensure it maintains a first mover advantage as it
enters new markets and is committed to differentiate itself by deploying resources in markets with major
opportunities. The Company operates a portfolio of brands which cater to a wide community of cannabis
consumers, with focus on quality and consistency.
Chemesis has facilities in both Puerto Rico and California, and is in the process of constructing a GMP
certified facility in Colombia. Chemesis’ Puerto Rico operations are licensed to operate 100,000 ft 2 of
cultivation, and 35,000 ft 2 of manufacturing floor space. The Company is positioned to win additional
licenses in highly competitive merit-based US states, and will expand its footprint to ensure it maintains a
first mover advantage.
Investor Relations:
1 (604) 398-3378
Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
Jay&SB.instagram
Forward-Looking Information: This news release contains "forward -looking information" within the meaning of
applicable securities laws relating to statements regarding the Company's business, products and future of the
Company’s business, its product offerings and plans for sales and marketing, including finalizing an acquisition in
Colombia. Although the Company believes that the expecta tions reflected in the forward -looking information are
reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to
place undue reliance on forward -looking information. Such forward -looking statements are subject to risks and
uncertainties that may cause actual results, performance and developments to differ materially from those
contemplated by these statements depending on, among other things, the risks that the Company's products and
plan will vary from those stated in this news release and the Company may not be able to carry out its business plans
as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend to update
any forward-looking statements or forward-looking information in this news release. Although the Company believes
that the expectations reflected in the forward -looking information are reasonable, there can be no assurance that
such expectations will prove to be correct and makes no reference to profitability based on sales reported. The
statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release